Seoulin Bioscience Valuation
| 038070 Stock | KRW 7,340 230.00 3.23% |
At this time, the company appears to be overvalued. Seoulin Bioscience CoLtd has a current Real Value of W6230.59 per share. The regular price of the company is W7340.0. Our model measures the value of Seoulin Bioscience CoLtd from inspecting the company fundamentals such as Shares Outstanding of 7.3 M, operating margin of 0.1 %, and Return On Equity of 10.81 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Seoulin Bioscience's price fluctuation is very steady at this time. Calculation of the real value of Seoulin Bioscience CoLtd is based on 3 months time horizon. Increasing Seoulin Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Seoulin Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Seoulin Stock. However, Seoulin Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7340.0 | Real 6230.59 | Hype 7340.0 | Naive 6179.57 |
The real value of Seoulin Stock, also known as its intrinsic value, is the underlying worth of Seoulin Bioscience CoLtd Company, which is reflected in its stock price. It is based on Seoulin Bioscience's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Seoulin Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Seoulin Bioscience CoLtd helps investors to forecast how Seoulin stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Seoulin Bioscience more accurately as focusing exclusively on Seoulin Bioscience's fundamentals will not take into account other important factors: Seoulin Bioscience Total Value Analysis
Seoulin Bioscience CoLtd is presently forecasted to have takeover price of 165.44 B with market capitalization of 85.27 B, debt of 15.22 B, and cash on hands of 14.97 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Seoulin Bioscience fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
165.44 B | 85.27 B | 15.22 B | 14.97 B |
Seoulin Bioscience Investor Information
About 31.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Seoulin Bioscience CoLtd had 1:1 split on the 30th of September 2024. Based on the measurements of operating efficiency obtained from Seoulin Bioscience's historical financial statements, Seoulin Bioscience CoLtd is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Seoulin Bioscience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Seoulin Bioscience has an asset utilization ratio of 59.1 percent. This suggests that the Company is making W0.59 for each dollar of assets. An increasing asset utilization means that Seoulin Bioscience CoLtd is more efficient with each dollar of assets it utilizes for everyday operations.Seoulin Bioscience Ownership Allocation
The market capitalization of Seoulin Bioscience is W85.27 Billion. Seoulin Bioscience CoLtd maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.Seoulin Bioscience Profitability Analysis
The company reported the revenue of 80.72 B. Net Income was 15.77 B with profit before overhead, payroll, taxes, and interest of 16.52 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Seoulin Bioscience's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Seoulin Bioscience and how it compares across the competition.
About Seoulin Bioscience Valuation
The stock valuation mechanism determines Seoulin Bioscience's current worth on a weekly basis. Our valuation model uses a comparative analysis of Seoulin Bioscience. We calculate exposure to Seoulin Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Seoulin Bioscience's related companies.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company was founded in 1984 and is headquartered in Seongnam, South Korea. SeouLin is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Seoulin Bioscience's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Seoulin Bioscience's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Seoulin Bioscience's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Seoulin Bioscience's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Seoulin Bioscience's revenue streams: Identify Seoulin Bioscience's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Seoulin Bioscience's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Seoulin Bioscience's growth potential: Evaluate Seoulin Bioscience's management, business model, and growth potential.
- Determine Seoulin Bioscience's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Seoulin Bioscience's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Seoulin Stock analysis
When running Seoulin Bioscience's price analysis, check to measure Seoulin Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seoulin Bioscience is operating at the current time. Most of Seoulin Bioscience's value examination focuses on studying past and present price action to predict the probability of Seoulin Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seoulin Bioscience's price. Additionally, you may evaluate how the addition of Seoulin Bioscience to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |